Corpus ID: 1585720

Therapeutic effects of dopamine D1/D2 receptor agonists on detrusor hyperreflexia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian cynomolgus monkeys.

@article{Yoshimura1998TherapeuticEO,
  title={Therapeutic effects of dopamine D1/D2 receptor agonists on detrusor hyperreflexia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian cynomolgus monkeys.},
  author={N. Yoshimura and E. Mizuta and O. Yoshida and S. Kuno},
  journal={The Journal of pharmacology and experimental therapeutics},
  year={1998},
  volume={286 1},
  pages={
          228-33
        }
}
The effects of dopamine receptor agonists on urinary bladder function were evaluated in normal and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned parkinsonian cynomolgus monkeys to investigate the therapeutic efficacy in the treatment of urinary symptoms in Parkinson's disease. Under ketamine anesthesia, cystometrograms exhibited significant reduction in the volume threshold for the micturition reflex in MPTP-lesioned parkinsonian monkeys when compared with those of normal monkeys… Expand
101 Citations
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 40 REFERENCES
Combination treatment of the partial D2 agonist terguride with the D1 agonist SKF 82958 in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian cynomolgus monkeys.
Bladder hyperreflexia induced in marmosets by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
The rationale for the use of dopamine agonists in Parkinson's disease
D1 and D2 dopamine receptor mechanisms in dopaminergic behaviors.
Dopamine D-1 receptors in the parkinsonian brain
Dopamine receptor pharmacology.
...
1
2
3
4
...